EWTX
Ticker
Edgewise Therapeutics, Inc.
EWTX · Healthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…Edgewise Therapeutics, Inc. (EWTX), in the Healthcare sector, has 13 disclosed filings on Paydirt over the trailing twelve months from 7 corporate insiders: 1 purchase and 12 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 13 and filed Aug 14. The most active filer was Joanne M. Donovan with 7 filings.
Add to watchlistFilings, ttm
13
1 buy · 12 sells
Traders, ttm
7
7 insiders
Volume, ttmiDollar value disclosed in the window
$19.4M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Aug 13
Filed Aug 14
ADViAverage daily dollar volume
$64.2M
market data
Share price · 12M
$43.75 (+189.7%)
Adjusted for splits and dividends.
Volume by month
Buys $20.2M
Sells $25.8M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
JDRecent filings
Joanne M. DonovanSALE
CMO
$372K8,537 sh across 3 lots
Exec Aug 12
Filed Aug 14 · 4:54 PM ET Alan J RussellSALE Chief Scientific Officer $141K
3,238 sh × $43.68
Exec Aug 12
Filed Aug 14 · 4:53 PM ET John R MooreSALE General Counsel $213K
4,858 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 4:53 PM ET Behrad DerakhshanSALE Chief Business Officer $108K
2,475 sh × $43.70
Exec Aug 12
Filed Aug 14 · 4:53 PM ET Kevin KochSALE President and CEO $745K
17,058 sh across 2 lots
Exec Aug 12
Filed Aug 14 · 4:52 PM ET Alan J RussellSALE Chief Scientific Officer $7.9M
200,000 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 5:21 PM ET Joanne M. DonovanSALE CMO $2.1M
55,230 sh across 2 lots
Exec May 4
Filed May 5 · 5:30 PM ET Joanne M. DonovanSALE CMO $926K
28,662 sh × $32.31
Exec Apr 1
Filed Apr 2 · 5:30 PM ET Joanne M. DonovanSALE CMO $685K
21,338 sh × $32.12
Exec Mar 31
Filed Mar 31 · 5:30 PM ET Joanne M. DonovanSALE CMO $507K
16,358 sh across 2 lots
Exec Mar 27
Filed Mar 30 · 5:30 PM ET Badreddin EdrisSALE Director $3.4M
115,471 sh across 5 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET Jonathan C FoxPURCHASE Director $199K
10,700 sh × $18.64
Exec Nov 11 2025
Filed Nov 13 2025 · 6:04 PM ET Alan J RussellSALE Chief Scientific Officer $2.1M
100,000 sh × $21.12
Exec Nov 12 2025
Filed Nov 13 2025 · 5:30 PM ET Alan J RussellSALE Chief Scientific Officer $1.5M
100,000 sh × $14.60
Exec Aug 26 2025
Filed Aug 28 2025 · 5:30 PM ET Kevin KochSALE President and CEO $107K
7,972 sh × $13.39
Exec Aug 12 2025
Filed Aug 14 2025 · 5:30 PM ET OrbiMed Genesis GP LLCPURCHASE Director $10.0M
496,771 sh across 2 lots
Exec Apr 3 2025
Filed Apr 4 2025 · 5:30 PM ET Peter A. ThompsonPURCHASE Director $10.0M
496,771 sh across 2 lots
Exec Apr 3 2025
Filed Apr 4 2025 · 5:30 PM ET Behrad DerakhshanSALE Chief Business Officer $300K
10,000 sh × $30.03
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET Kevin KochSALE President and CEO $259K
8,636 sh × $30.03
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET Alan J RussellSALE Chief Scientific Officer $241K
8,015 sh × $30.02
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET Joanne M. DonovanSALE CMO $691K
25,000 sh × $27.63
Exec Jan 28 2025
Filed Jan 30 2025 · 5:30 PM ET Alan J RussellSALE Chief Scientific Officer $2.7M
100,000 sh × $27.37
Exec Dec 30 2024
Filed Dec 31 2024 · 5:30 PM ET Marc SemigranSALE Chief Development Officer $830K
27,980 sh × $29.66
Exec Dec 24 2024
Filed Dec 27 2024 · 5:30 PM ET R Michael CarruthersSALE Chief Financial Officer $3.6M
125,092 sh across 4 lots
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET Behrad DerakhshanSALE Chief Business Officer $1.2M
42,068 sh × $29.03
Exec Sep 20 2024
Filed Sep 24 2024 · 5:30 PM ET